Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases

被引:22
作者
Shoji, Jun [1 ]
机构
[1] Nihon Univ, Dept Visual Sci, Div Ophthalmol, Sch Med,Itabashi Ku, 30-1 Ohyaguchi Kamicho, Tokyo 1738610, Japan
关键词
Eosinophil cationic protein; Eotaxin-2; Histamine H-4 receptor; Ocular allergy test; Th2; chemokine; EOSINOPHIL CATIONIC PROTEIN; ATOPIC KERATOCONJUNCTIVITIS; VERNAL KERATOCONJUNCTIVITIS; H4; RECEPTORS; H-4; RECEPTOR; TEAR LEVELS; EOTAXIN; EXPRESSION; PERIOSTIN; INFLAMMATION;
D O I
10.1016/j.alit.2020.05.003
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Allergic conjunctival diseases (ACDs) are inflammatory diseases of the conjunctiva and cornea caused predominantly by the IgE-mediated immediate hypersensitivity response. Allergic conjunctival diseases include allergic conjunctivitis, vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC), and giant papillary conjunctivitis. In clinical practice of ACDs, an ocular allergy test using biomarker measurement is a crucial examination technique for diagnosing, evaluating severity, and determining the efficacy of medical treatment. The ocular allergy test includes the tear test for evaluating the concentration of biomarkers in tears and an ocular surface test for assessing the expression levels of messenger ribonucleic acid (mRNA) biomarkers on the ocular surface. The clinical usefulness of several biomarkers has been demonstrated in patients with ACDs; specifically, eosinophil cationic protein and eotaxin-2 as eosinophilic inflammation biomarkers; interleukin-4 and thymus and activation regulated chemokine (CCL17/TARC) as Th2 inflammation biomarkers; eotaxin, tumor necrosis factor-alpha and soluble IL-6 receptor as giant papillae biomarkers; and osteopontin and periostin as allergic inflammation and remodeling biomarkers. Furthermore, the ocular allergy test, quantitative evaluation methods using biomarkers have allowed for better understanding of the immunological and pathophysiological mechanisms of ACDs. Therefore, the search for a biomarker is important to make an ocular allergy test useful. In previous ocular allergy tests, the biomarkers for allergic inflammation in patients with chronic ACDs including VKC and AKC were substantial. However, the selection of biomarkers associated with the early phase reaction of immediate hypersensitivity and innate immunity responses needs to be addressed in future investigations. Copyright (C) 2020, Japanese Society of Allergology. Production and hosting by Elsevier B.V.
引用
收藏
页码:496 / 504
页数:9
相关论文
共 50 条
  • [21] To See or Not to See: A Systematic Review of the Importance of Human Ocular Surface Cytokine Biosignatures in Ocular Allergy
    Aydin, Esrin
    Gokhale, Moneisha
    Azizoglu, Serap
    Suphioglu, Cenk
    [J]. CELLS, 2019, 8 (06)
  • [22] Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis
    Bonini, Stefano
    Lambiase, Alessandro
    Sgrulletta, Roberto
    Bonini, Sergio
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 3 (05) : 381 - 387
  • [23] Biomarkers of ocular surface disease using impression cytology
    Hagan, Suzanne
    [J]. BIOMARKERS IN MEDICINE, 2017, 11 (12) : 1135 - 1147
  • [24] The evolution of cyclosporine treatments for treatment of ocular surface diseases
    Flts, Anna
    Medina, Richard
    Akpek, Esen K.
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 24 (05) : 360 - 367
  • [25] The role of regulated necrosis in inflammation and ocular surface diseases
    Guo, Xiao-Xiao
    Pu, Qi
    Hu, Jing-Jie
    Chang, Xue-Jiao
    Li, Ao-Ling
    Li, Xin-Yu
    [J]. EXPERIMENTAL EYE RESEARCH, 2023, 233
  • [26] Antigen-presenting cells in ocular surface diseases
    Kalogeropoulos, Dimitrios
    Papoudou-Bai, Alexandra
    Lane, Mark
    Goussia, Anna
    Charchanti, Antonia
    Moschos, Marilita M.
    Kanavaros, Panagiotis
    Kalogeropoulos, Chris
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (06) : 1603 - 1618
  • [27] Intense pulsed light therapy for ocular surface diseases
    Chen, Ruida
    Lu, Jiale
    Dong, Jilian
    Zhu, Yirui
    [J]. LASERS IN MEDICAL SCIENCE, 2024, 39 (01)
  • [28] The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases
    Mantelli, Flavio
    Mauris, Jerome
    Argueeso, Pablo
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 13 (05) : 563 - 568
  • [29] Ocular Surface Reconstruction With a Tissue-Engineered Nasal Mucosal Epithelial Cell Sheet for the Treatment of Severe Ocular Surface Diseases
    Kobayashi, Masakazu
    Nakamura, Takahiro
    Yasuda, Makoto
    Hata, Yuiko
    Okura, Shoki
    Iwamoto, Miyu
    Nagata, Maho
    Fullwood, Nigel J.
    Koizumi, Noriko
    Hisa, Yasuo
    Kinoshita, Shigeru
    [J]. STEM CELLS TRANSLATIONAL MEDICINE, 2015, 4 (01) : 99 - 109
  • [30] Ocular surface pseudoepitheliomatous hyperplasia secondary to allergic eye disease: clinical features and management
    Nibandhe, Ananya
    Kaliki, Swathi
    Jakati, Saumya
    Shanbhag, Swapna
    Basu, Sayan
    Donthineni, Pragnya Rao
    [J]. EYE, 2024, 38 (07) : 1320 - 1326